+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Epithelial Ovarian Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Treatment Market - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Treatment Market

  • Report
  • September 2025
  • 150 Pages
  • Global
From
Ovarian Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Ovarian Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Breast Cancer Drugs Market Report 2026 - Product Thumbnail Image

Breast Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Sinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Sinusitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Thyroid Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Cystic Fibrosis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cystic Fibrosis Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
From
From
From
Biosimilar Growth Hormones Market Report 2026 - Product Thumbnail Image

Biosimilar Growth Hormones Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
HER2 Positive Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2 Positive Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Interferon - Global Strategic Business Report - Product Thumbnail Image

Interferon - Global Strategic Business Report

  • Report
  • May 2026
  • 153 Pages
  • Global
From
HER2 Antibodies - Global Strategic Business Report - Product Thumbnail Image

HER2 Antibodies - Global Strategic Business Report

  • Report
  • May 2026
  • 137 Pages
  • Global
From
Loading Indicator